In a report published Thursday, Morgan Stanley analyst Fotis Giannakoulis reiterated an Overweight rating on Costamare CMRE, but removed the $22.00 price target.
In the report, Morgan Stanley noted, “2Q14 results well above consensus on lower expenses. CMRE reported adjusted EPS of $0.48, surpassing our $0.32 estimate and consensus' $0.38. Revenue of $124m was +7% QoQ and +22% YoY, matching our expectations, but cash expenses came 13% below our forecast with average daily costs falling 5% YoY. As a result, adjusted EBITDA of $87m (+8% QoQ, +29% YoY) beat our estimates by 5%.”
Costamare closed on Wednesday at $23.44.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in